Navigation Links
Prescient Medical, Inc. to Present Data on Identification and Treatment of Rupture-Prone Coronary Plaques at EuroPCR 2008

Company Pursues Strategy of Reducing Heart Attack Deaths by Shielding

High-Risk Plaques in Coronary Arteries

DOYLESTOWN, Pa., May 8 /PRNewswire/ --- Prescient Medical, Inc., a privately held medical device company dedicated to reducing deaths from heart attacks, will present new experimental results on the chemical characterization and treatment of rupture-prone or "vulnerable" plaques, with a focus on the vPredict(TM) Optical Catheter System and the vProtect(TM) Luminal Shield, at the upcoming EuroPCR 2008 conference to be held in Barcelona, Spain from May 13 to 16.

The vProtect Luminal Shield was designed by Prescient Medical to treat soft, atherosclerotic lesions that may be at risk of rupture or that have recently ruptured. The self-expanding design of vProtect is a departure from the balloon-expandable stents that are mainstays of current focal treatment for coronary artery disease (CAD). The vProtect Luminal Shield has been designed to limit complications commonly associated with the insertion of stents, including vessel injury, restenosis, neointimal hyperplasia, and thrombosis.

The presentations will be an integral part of a session entitled "Glimpse Into The Future: Current Understanding of High-Risk Atherosclerosis Coronary Lesions," which will be held on May 14, 2008 from 13:30 to 16:50 in Room 5 of the conference. Professor Patrick Serruys, head of the Erasmus Medical Center's Department of Interventional Cardiology, will co-chair the session, which features presentations from leading authorities on coronary artery disease, including Dr. Guillermo Tearney, a distinguished researcher on the development and validation of new optical diagnostic technologies at Massachusetts General Hospital; and Dr. Juan Granada, Medical Director at the Jack H. Skirball Center for Cardiovascular Research. Dr. Tearney will present results from Prescient's vPredict Optical Catheter System in his presentation, "Spectroscopy Imaging of Coronary Lesions: Compositional Assessment". Dr. Granada will reveal the latest results obtained with the vProtect Luminal Shield in "Shielding for High-Risk Plaque."

Prescient Medical is dedicated to providing interventional cardiologists with new methods for effectively addressing different plaque types through enhanced conformability and adaptability of the Shield device to vessel structure, morphology, and dynamic forces. According to Dr. Granada, vProtect represents a revolutionary departure from the use of rigid balloon-expandable stents for coronary artery disease: "The vProtect Luminal Shield is the first step toward the goal of creating products that will achieve plaque stabilization and promote vascular healing. Prescient Medical has designed this device to conform to the physiology of the coronary arteries, rather than force the arteries to conform to a rigid metal scaffold."

For more information on Prescient Medical or its products, as well as the presentations of Professor Serruys, Dr. Tearney, or Dr. Granada, please contact Ilana Odess, General Manager of Prescient Medical, at (917) 941-9990. Ms. Odess will be available to meet with representatives of the medical community throughout the conference at the Rafael Hoteles Diagonal Port, Estrellas, C/Lope de Vega, 4, 08005, 34-932-302 000- Suite Clave (201).

About Prescient Medical, Inc.

Prescient Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. For more information, please visit our website at or call 866-376-0500.

SOURCE Prescient Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
3. Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results
4. Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results
5. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
6. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
7. Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM)
8. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
9. Tryton Medical, Inc. Closes $14 Million Financing
10. China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.
11. Cohera Medical, Inc. Announces Closing of Insider Round of Financing for Over $7.6 Million
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... , Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider ... , today announced that the company has set a new ... 391% quarter on quarter growth posted for Q3 of 2014 to ... and Mexico , with the establishment of an ... 2015. --> United Kingdom and ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology:
(Date:11/17/2015)... 2015  Vigilant Solutions announces today that Mr. ... Directors. --> --> ... the partnership at TPG Capital, one of the largest ... Billion in revenue.  He founded and led TPG,s Operating ... companies, from 1997 to 2013.  In his first role, ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
Breaking Biology News(10 mins):